Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
14.72
-0.71 (-4.60%)
At close: Aug 11, 2026, 4:00 PM EDT
14.75
+0.03 (0.20%)
After-hours: Aug 11, 2026, 7:53 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $695.28 million as of August 11, 2026. Its market cap has increased by 192.06% in one year.
Market Cap
695.28M
Enterprise Value
623.34M
1-Year Change
192.06%
Ranking
Category
Stock Price
$14.72
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from $538.37M to $695.28M, an increase of 29.15%. That is a compound annual growth rate of 4.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 695.28M | 142.11% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 750.66M |
| Allogene Therapeutics | 742.08M |
| Crescent Biopharma | 741.96M |
| BridgeBio Oncology Therapeutics | 738.19M |
| AgomAb Therapeutics NV | 733.30M |
| Immix Biopharma | 714.68M |
| Achieve Life Sciences | 713.48M |
| Gyre Therapeutics | 712.55M |